FDA Investigator Kenneth H Williams

Kenneth H Williams has inspections in 15 countries as of 03 Nov 2023. Kenneth H Williams has collaborated with a combinined 7003 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
81
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Germany, Canada, United States of America, Italy, Trinidad and Tobago, Spain, Bahamas, India, Ireland, China, France, Sweden, Norway, Argentina, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Abby E Pelletier, Abdur Rafay Shareef, Ademola O Daramola, Aditi S Thakur, Aireen V Mendoza, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alberto A Viciedo, Albinus D'sa, PhD, Albinus M D Sa, Alice S Tsao, Althea A Williams, Amatul H Marium, Amber G Wardwell, Ana P Barido, Andrea A Branche, Andrew M Barlow, Angela E Glenn, Anissa M Vargas, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Anna Lazar, Anthony C Warchut, Anthony J Ladner, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Azza Talaat, Barbara I Rogolsky, Barbara L Rogolsky, Bijoy Panicker, Binh T Nguyen, Blondell W Johnson, Bogdan Kurtyka, Bonita S Chester, Brandon C Heitmeier, Brandy N Lepage, Brenda P King, Brenda W Uratani, PhD, Brett R Havranek, Brien C Fox, Brooke K Higgins, Camerson E Moore, Carla J Lundi, Carolina D Vasquez, Carr Sharpe, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Celia N Cruz, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Chelsea N Sealey, Cheryl A Clausen, Christian Parra, Christina Capacci Daniel, PhD, Christopher D Leach, Christopher Janik, Christopher T Middendorf, Concepcion Cruz, Jr, Constance Desimone, Craig T Rybus, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Cynthia R Gibson, Cynthia T Cain, Dale A Nyberg, Daniel J Roberts, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, David A Oluwo, David M Beltran, David R Delucia, Deborah A Greco, Debra I Love, Debra J Bennett, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Devaugh Edwards, Devaughn Edwards, Deyaa Shaheen, Diane C Thibodeau, Diane L Raccasi, Dien N Nguyen, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Donna Mwilliams Hill, Douglas C Kovacs, Douglas Florentino, Dr. Carmelo Rosa, Dr. Gopa Biswas, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth Ll Edwards, Ellen P Madigan, Eric M Mueller, PharmD, Erik W Koester, Esther B Gamallo Herrera, Farhana Khan, Felix Maldonado, Francis A Guidry, Frank Wackes, Gary J Lehr, Gary T Greco, Gayle S Lawson, Gene D Arcy, George J Flynn, George Pyramides, Geraldine D Sanders, Geraldine Sanders, Ginger M Sykes, Grace E Mcnally, Hasan A Irier, PhD, Heidy C Perales, Helen B Ricalde, Helen Verdel, Henry E Sanchez, Holly Brevig, Ivis Lnegron Torres, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, James L Dunnie, Jr, James M Timper Jr, James S Cartwright, Jared P Stevens, Javier O Vega, Jawaid Hamid, Jeffrey B Medwid, PhD, Joel D Hustedt, Jogy George, John A Gonzalez, John A Podsadowski, John J Thibodeau, John P Mistler, Jonah S Ufferfilge, Jonathan G Matrisciano, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose O Hernandez, Joseph Maselli, Joshua P Wireman, Julianne C Mccullough, June P Page, Justin A Boyd, Justine M Corson, Justine Tomasso, Kara D Dobbin, Karen K Moksnes, Karen L Kosar, Karen Mcnabb Noon, Karen Takahashi, Kari M Johansen, Karishma G Gopaul, Katherine D Adams, Katherine Szestypalow, Kathleen D Culver, Kathy Chiu, Kathy Kuo, Katie L Korchinski, Kazi Rafiquzzaman, Kellia N Hicks, Kenneth M Gordon, Kevin A Gonzalez, Kevin D Kallander, Kevin P Regan, Kham Phommachanh, Kim Lthomas Cruse, Kim Thomas Chase, Kim Thomasc Rice, Krishna Ghosh, PhD, Kristen D Evans, Kristina L Conroy, L Gnnmassimia Massimilla, PharmD, Larry K Austin, Latorie S Jones, Laurie B Frazier, Lawrence W Farina, LCDR Debra Emerson, LCDR Michael H Tollon, Liming Zhang, Linda F Murphy, Linda K Cline, Linda L Green, Linda Thai, Lindsey M Schwierjohann, Lisa R Hilliar, Logan T Williams, Lori M Newman, LT Richard A Lyght, Luis A Dasta, Luis M Burgos Medero, Lydia Irosas Marty, Lynda L Perry, PhD, Lynnette I Riggio, Makini Cobourne Duval, PhD, Mamta Gautam Basak, PhD, Margaret E Sarles, Margaret M Annes, Maria Pkelly Doggett, MBA, Maria V Price, Maridalia Torres Irizarry, Marie A Fadden, Mark E Parmon, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Maryam Tabatabaie, Marybet Lopez, Matthew A Spataro, Matthew B Casale, Matthew C Watson, Matthew M Henciak, Maya M Davis, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melissa I Michurski, Melissa J Garcia, Merideth K Rose, Meyer J Slobotsky, Michael A Charles, Michael D Garcia, Michael L Casner, Michael Levin, Michael P Sheehan, Michael R Goga, Michele Gottshall, Michele L Obert, Michele Perry Williams, Michelle M Noe, Miguel A Martinez, Milva E Melendez, Mindy M Chou, Minh D Phan, Mohsen Rajabi Abhari, FDA, Monique C Lo, Mra Davism, Mra M Barbosar, Muralidhara B Gavini, PhD, Nancy A Saxenian, Nancy A Saxenian Emmons, Nancy L Rolli, Nancy N Bellamy, Nathan B Davis, Nealie C Newberger, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas L Hunt, Nicholas L Paulin, Nicole E Knowlton, Nikki S Ramirez, Pamela L Ogonowski, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula M Laplant, Pei I Chu, Penny H Mccarver, Perry T Nichols, Peter Abel, Peter Caparelli, Peter E Baker, Peter R Caparelli, Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Phyllis J Wilson, Qin Xu, Rachael A Moliver, Raeann R Wu, Rafael Nevarez Nieves, Rafeeq A Habeeb, Rajiv R Srivastava, Ralph H Vocque, Ramon A Hernandez, Ramon E Martinez, Reba A Gates, Rebecca E Dombrowski, Richard H Penta, Rita K Kabaso, Robert C Coleman, Robert C Steyert, Robert J Ham, Robert J Martin, Robert Mo Brien, Rochelle K Kimmel, Rochelle L Cross, Rory K Geyer, Rosanna M Goodrich, Rose M Ashley, Rozelle G Smith, Russell K Riley, Saied A Asbagh, Saleem A Akhtar, Samina S Khan, Samuel K Mathew, Samuel Mathew, Samuel T Walker, Sandra P White, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Sarah E Mcmullen, Sarah M Meng, Satheesh Thomas, Scott B Laufenberg, Scott T Ballard, Sean P Desbrow, Sean R Marcsisin, Seneca D Toms, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shirley J Berryman, Shirley S Wen, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie A Slater, MS, Stephen D Brown, Stephen D Eich, Stephen J Mottola, Steven A Gonzales, Steven Frisbee, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Tamala P Bogan, Tamala P Magee, Tamil Arasu, PhD, Teresa I Navas, Terri L Dodds, Thomas J Arista, Thomas J Mooney, Tiara M Brown, Tiara Nbrown Crosen, Timothy T Kapsala, Tina M Pawlowski, Torrance J Slayton, Towanda L Terrell, Tracy M Portelli, Travis R Hunt, Truong Xuan Nguyen (Andy), Uduak M Inokon, Uttaniti Limchumroon (Tom), Valentino Fiorella, Vani Mathur Richards, Verlinda A Narcisse, Victoria M Daddeo, Vilmary Negron Rodriguez, Vioela J Caze, Virgilio F Pacio, CSO, Vlada Matusovsky, Walden H Lee, William A Warnick, William J Leonard, Winston R Alejo, Xiaokuang Lai, PhD, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Yuyan Liang, Yvins Dezan, Zachary A Bogorad, Zhaoyang Meng

Kenneth H Williams's Documents

Publish Date Document Type Title
June, 2019 FDA 483 Response Maprimed S.A. - Form 483R, 2019-06-28
April, 2008 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2008-04-04
November, 2002 EIR Leo Pharma Manufacturing Italy SRL. - EIR, 2002-11-25
September, 2005 EIR Contract Pharmaceuticals Limited Canada - EIR, 2005-09-01
May, 2019 FDA 483 CGA Limited - Form 483, 2019-05-31
May, 2008 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2008-05-15
August, 2002 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2002-08-07
September, 2016 FDA 483 Response Vertex Pharmaceuticals Incorporated - Form 483R, 2016-10-11
April, 2017 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2017-04-04
February, 2003 FDA 483 Cambrex - Form 483, 2003-02-11
February, 2003 FDA 483 Response Cambrex - Form 483R, 2003-03-25
May, 2019 FDA 483 Coral Pharmaceuticals LTD - Form 483, 2019-05-24
October, 2002 FDA 483 Response AbbVie Deutschland GmbH & Co KG - Form 483R, 2002-11-20
August, 2012 FDA 483 Columbia Presbyterian Medical Center - Form 483, 2012-08-10
January, 2010 FDA 483 Johnson Matthey Pharmaceutical Materials, Inc. - Form 483, 2010-01-15
October, 2002 FDA 483 Response Bayer Healthcare Manufacturing Srl - Form 483R, 2002-10-31
April, 2017 FDA 483 Response DR. REDDY'S LABORATORIES LIMITED - Form 483R, 2017-04-19
December, 2011 FDA 483 Cubist Pharmaceuticals, Inc. - Form 483, 2011-12-09
August, 2005 FDA 483 Barr Laboratories Inc. - Form 483, 2005-08-25
July, 2000 FDA 483 Response Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483R, 2000-07-25
November, 2003 EIR Patheon Inc. - EIR, 2003-11-14
October, 2019 FDA 483 Apitoria Pharma Private Limited - Form 483, 2019-10-25
September, 2005 EIR Patheon Inc. - EIR, 2005-09-08
August, 2002 EIR Fougera Pharmaceuticals Inc. - EIR, 2002-08-07
October, 2005 FDA 483 Sheffield Pharmaceuticals LLC - Form 483, 2005-10-19
November, 2003 FDA 483 Response Patheon Inc. - Form 483R, 2003-12-05
July, 2000 FDA 483 Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483, 2000-07-21
June, 2012 FDA 483 Response Momenta Pharmaceuticals, Inc. - Form 483R, 2012-06-20
July, 2017 FDA 483 Polypeptide Laboratories Inc - Form 483, 2017-07-19
June, 2012 EIR Momenta Pharmaceuticals, Inc. - EIR, 2012-06-08
October, 2002 EIR Bayer Healthcare Manufacturing Srl - EIR, 2002-10-31
August, 2002 FDA 483 Response Fougera Pharmaceuticals Inc. - Form 483R, 2002-08-19
March, 2009 FDA 483 Somerset Therapeutics Limited - Form 483, 2009-04-01
October, 2001 FDA 483 Boston Analytical - Form 483, 2001-10-04
September, 2005 FDA 483 Contract Pharmaceuticals Limited Canada - Form 483, 2005-09-01
June, 2011 FDA 483 Boston Analytical - Form 483, 2011-06-16
August, 2002 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2002-08-07
June, 2019 EIR Maprimed S.A. - EIR, 2019-06-07
June, 2009 FDA 483 Curia Massachusetts, Inc. - Form 483, 2009-06-12
April, 2017 EIR DR. REDDY'S LABORATORIES LIMITED - EIR, 2017-04-04
November, 2002 FDA 483 Response Leo Pharma Manufacturing Italy SRL. - Form 483R, 2002-12-02
October, 2002 EIR AbbVie Deutschland GmbH & Co KG - EIR, 2002-10-25
November, 2003 FDA 483 Patheon Inc. - Form 483, 2003-11-14
October, 2002 FDA 483 AbbVie Deutschland GmbH & Co KG - Form 483, 2002-10-25
August, 2005 EIR Barr Laboratories Inc. - EIR, 2005-08-25
February, 2003 EIR Cambrex - EIR, 2003-02-11
June, 2012 FDA 483 Momenta Pharmaceuticals, Inc. - Form 483, 2012-06-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more